Our results support previous studies, which indicate a significant correlation between reduced AJAP1 mRNA levels and an increased tumor vascularization in patients with hepatocellular carcinoma (Ezaka et al., 2015). The gene discussed is AJAP1; the disease is hepatocellular carcinoma.